ACC.20/WCC Highlights Podcast Part 1 of 3

Order of abstracts:

1. Armstrong et al – VICTORIA trial – Vericiguat shows beneficial effects in very high-risk HF population
2. Bonaca et al – VOYAGER-PAD trial – Rivaroxaban and aspirin effective and safe for PAD patients
3. Pereira et al – TAILOR-PCI trial – TAILOR-PCI misses endpoint but still provides valuable insights
4. Leon et al – PARTNER 3 trial – 2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
5. Agnelli et al – CARAVAGGIO trial – Apixaban offers new perspective for cancer patients in need of anticoagulation
6. Samama et al – Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery